RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $74 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Brian Abrahams has reiterated a Sector Perform rating on Gilead Sciences (NASDAQ:GILD) and maintained a $74 price target.
June 14, 2024 | 1:58 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital has reiterated a Sector Perform rating on Gilead Sciences and maintained a $74 price target. This suggests that the analyst expects the stock to perform in line with the sector.
The reiteration of a Sector Perform rating and maintenance of the $74 price target indicates that RBC Capital does not foresee significant short-term changes in Gilead Sciences' stock performance relative to its sector. This is a neutral signal for investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100